Natasa Zamurovic Ribrioux

Company: Novartis
Job title: Strategy & Portfolio Director-Preclinical Safety/ Translational Medicine
Bio:
Understanding preclinical species selection to accurately assess pharmacology and safety of targeted protein degraders
For more information on this session, please download the full event guide.
Day: Pre-Conference Workshop Day